ArticleScientific reports2019

Combination effect of lapatinib with foretinib in HER2 and MET co-activated experimental esophageal adenocarcinoma.

Md Sazzad Hassan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.